IKK-alpha proteins, nucleic acids and methods
AssigneeAmgen Inc.
InventorsMike Rothe, Zhaodan Cao, Catherine Regnier
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions relating to an IκB kinase, IKK-α, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed IKK-α encoding nucleic acids or purified from human cells. The invention provides isolated IKK-α hybridization probes and primers capable of specifically hybridizing with the disclosed IKK-α genes, IKK-α-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
Claims11
An isolated IKK-αGlu543 polypeptide, comprising at least 10 consecutive amino acid residues of the amino acid sequence set forth as SEQ ID NO:4, which consecutive amino acid residues comprise the amino acid residue 543 (Glu) of SEQ ID NO:4.
An isolated or recombinant IKK-αA1628 nucleic acid comprising at least 24 consecutive nucleotides of the nucleotide sequence set forth as SEQ ID NO:3, which consecutive polynucleotides comprise the polynucleotide 1628 (A) of SEQ ID NO:3.
A method of screening for an agent which modulates the interaction of an IKK polypeptide to a binding target, said method comprising the steps of:
- incubating a mixture comprising:
- an isolated polypeptide comprising SEQ ID NO:
- 2 or 4, or a deletion mutant thereof retaining IκB kinase activity, an IκB polypeptide comprising at least a six residue domain of a natural IκB comprising at least one of Ser32 and Ser 36, and a candidate agent;
- under conditions whereby, but for the presence of said agent, said polypeptide specifically phosphorylates said IκB polypeptide at at least one of said Ser32 and Ser36 at a reference activity;
- detecting the polypeptide-induced phosphorylation of said IκB polypeptide at at least one of said Ser32 and Ser36 to determine an agent-biased activity, wherein a difference between the agent-biased activity and the reference activity indicates that said agent modulates the ability of said polypeptide to specifically phosphorylate a IκB polypeptide.
A method for modulating signal transduction involving IκB in a cell, said method comprising the step of modulating IKK-α (SEQ ID NO:4) kinase activity.
Dependencies are inferred from the claim text.